Results 211 to 220 of about 280,649 (271)

Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines. [PDF]

Nat Commun
Chen W, Tompkins KR, Windsor IW, Martinez LT, Ramos M, Li W, Shrivastava S, Rajput S, Chang JS, Sahasrabudhe P, Fennell KF, McLellan TJ, West GM, Dizon KP, Yam A, Mitra S, Saha S, Sharaf D, McKeen AP, Cadima CI, Muik A, Swanson W, Munoz Moreno R, Mendoza Daroca P, Sahin U, Anderson AS, Wu H, Swanson KA, Modjarrad K.   +28 more
europepmc   +1 more source

Maternal influenza vaccination during pregnancy and risk of autism spectrum disorder in the offspring

JCPP Advances, EarlyView.
Abstract Background Vaccination has been proposed as a potential risk factor for autism spectrum disorder (ASD), contributing to public hesitancy and mistrust toward immunization. Influenza vaccination during pregnancy is considered safe and effective in preventing serious maternal complications and adverse birth outcomes associated with influenza ...
Shahar Neeman, Maor Hemo, Gal Meiri, Dorit Shmueli, Idan Menashe   +4 more
wiley   +1 more source

A qualitative analysis exploring barriers and enablers to distribution, delivery, and access to COVID-19 vaccines in Botswana. [PDF]

Front Health Serv
Tlhakanelo JT, Ataguba JE, Pagiwa V, Ramabu N, Kadimo K, Muriithi GN, Achala DM, Adote ENA, Mbachu CO, Beshah SA, Masuka N, Nwosu CO, Akazili J, Ifeanyi C, Molosiwa D.   +14 more
europepmc   +1 more source

Exploring the roles and impacts of pharmacists embedded in general practice: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background The role of the general practice pharmacist (GPP) in Australia is not yet clearly defined, and their clinical expertise remains underutilised in general practice settings. This may be attributed to a limited understanding of pharmacists' capabilities, which can hinder optimal GPP utilisation.
Christel Chandra, Brooke Bevis, Holly Foot, Nazanin Falconer   +3 more
wiley   +1 more source

Equitable access to COVID-19 vaccines in Botswana: a scoping review. [PDF]

Front Health Serv
Tlhakanelo JT, Ataguba JE, Pagiwa V, Ramabu N, Kadimo K, Molosiwa D, Muriithi GN, Achala DM, Adote ENA, Mbachu CO, Beshah SA, Masuka N, Nwosu CO, Akazili J, Ifeanyi C.   +14 more
europepmc   +1 more source

Identification of Clinical Factors Associated With the Immunogenicity of Homologous ChAdOx1‐nCoV‐19 Vaccine in Hemodialysis Patients

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang, Ping‐Hsun Wu, Li‐Yun Chang, Yu‐Ying Huang, Teng‐Hui Huang, Su‐Chu Lee, Yi‐wen Chiu, Shang‐Jyh Hwang, Tsun‐Yung Kuo, Mei‐Chuan Kuo   +9 more
wiley   +1 more source

Cardiovascular Sequelae of the COVID-19 Vaccines. [PDF]

Cureus
Nitz JN, Ruprecht KK, Henjum LJ, Matta AY, Shiferaw BT, Weber ZL, Jones JM, May R, Baio CJ, Fiala KJ, Abd-Elsayed AA.   +10 more
europepmc   +1 more source

Efficacy and Safety of mRNA-Based COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
Alkhidir M, Sridharan K.
europepmc   +1 more source

Don't You Know That You're Toxic? How Influencer‐Driven Misinformation Fuels Online Toxicity

Psychology &Marketing, EarlyView.
ABSTRACT Research on misinformation has focused on message content and cognitive bias, overlooking how source type shapes toxic engagement. This study addresses that gap by showing that influencer‐driven misinformation does not merely increase toxicity: it reconfigures its nature and persistence through relational and social influence mechanisms ...
Giandomenico Di Domenico, Federico Mangió, Denitsa Dineva   +2 more
wiley   +1 more source

The cost of delivering COVID-19 vaccines in four districts in Malawi. [PDF]

Cost Eff Resour Alloc
Ruisch A, Ntopi S, Mathur I, Conlin M, McCaffrey A, Walker DG, Suharlim C.   +6 more
europepmc   +1 more source